First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Large Volume Increase – Here’s Why

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw unusually-strong trading volume on Monday . Approximately 76,999 shares changed hands during mid-day trading, an increase of 283% from the previous session’s volume of 20,079 shares.The stock last traded at $201.91 and had previously closed at $199.85.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 0.6%

The company has a 50 day simple moving average of $186.08 and a 200-day simple moving average of $172.11. The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of 21.72 and a beta of 0.65.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Kingstone Capital Partners Texas LLC increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 913,142.7% in the second quarter. Kingstone Capital Partners Texas LLC now owns 15,324,213 shares of the company’s stock valued at $2,352,314,000 after purchasing an additional 15,322,535 shares in the last quarter. Royal Bank of Canada raised its stake in First Trust NYSE Arca Biotechnology Index Fund by 3.0% during the 1st quarter. Royal Bank of Canada now owns 158,789 shares of the company’s stock worth $27,012,000 after buying an additional 4,652 shares during the period. Envestnet Asset Management Inc. increased its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 0.4% during the third quarter. Envestnet Asset Management Inc. now owns 120,923 shares of the company’s stock valued at $21,680,000 after acquiring an additional 438 shares in the last quarter. Berger Financial Group Inc increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 2.2% during the 3rd quarter. Berger Financial Group Inc now owns 115,495 shares of the company’s stock valued at $20,707,000 after purchasing an additional 2,476 shares in the last quarter. Finally, RPG Investment Advisory LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 98.7% during the first quarter. RPG Investment Advisory LLC now owns 52,098 shares of the company’s stock worth $8,863,000 after buying an additional 25,874 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.